About the Authors
- Ying Wang
-
Contributed equally to this work with: Ying Wang, Wenli Gao
Affiliation Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
- Wenli Gao
-
Contributed equally to this work with: Ying Wang, Wenli Gao
Affiliation Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
- Yuri V. Svitkin
-
Affiliation Department of Biochemistry and Goodman Cancer Center, McGill University, Montreal, Quebec, Canada
- Annie Pei-Chun Chen
-
Affiliation Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
- Yung-Chi Cheng
-
* E-mail: yccheng@yale.edu
Affiliation Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
Competing Interests
A patent application was filed for the potential use of DCB-3503 for the treatment of cancer and autoimmune diseases with Yung-Chi Cheng as co-inventor. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: YW WG YCC. Performed the experiments: YW WG APCC. Analyzed the data: YW WG YVS YCC. Wrote the paper: YW WG YCC.